ABT - ABBOTT LABORATORIES

QQQ $ 459.86 $ 0.43 (0.09 %)

DIA $ 407.95 $ -1.96 (-0.48 %)

SPY $ 548.56 $ -1.34 (-0.24 %)

TLT $ 99.56 $ 0.56 (0.57 %)

GLD $ 232.35 $ 1.92 (0.83 %)

Previous Close

$ 113.1

Open

$ 114.29

Bid

$ 113.00 x 100

Ask

$ 121.00 x 220

Day's Range

$ 112.55 - $ 114.32

52 Week Range

$ 88.33 - $ 120.40

Volume

2,903,019

Average Volume

Market Cap

196.78B

Beta (5Y Monthly)

$ 0.75

PE Ratio (TTM)

$ 35.41

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.02)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-31-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	02-16-2024	12-31-2023	10-K
4	11-01-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	02-17-2023	12-31-2022	10-K
8	11-01-2022	09-30-2022	10-Q
9	08-02-2022	06-30-2022	10-Q
10	05-03-2022	03-31-2022	10-Q
11	02-18-2022	12-31-2021	10-K
12	11-03-2021	09-30-2021	10-Q
13	08-04-2021	06-30-2021	10-Q
14	05-05-2021	03-31-2021	10-Q
15	02-19-2021	12-31-2020	10-K
16	11-04-2020	09-30-2020	10-Q
17	07-29-2020	06-30-2020	10-Q
18	04-29-2020	03-31-2020	10-Q
19	02-21-2020	12-31-2019	10-K
20	10-31-2019	09-30-2019	10-Q
21	07-31-2019	06-30-2019	10-Q
22	05-01-2019	03-31-2019	10-Q
23	02-22-2019	12-31-2018	10-K
24	10-31-2018	09-30-2018	10-Q
25	08-01-2018	06-30-2018	10-Q
26	05-02-2018	03-31-2018	10-Q
27	02-16-2018	12-31-2017	10-K
28	11-02-2017	09-30-2017	10-Q
29	08-02-2017	06-30-2017	10-Q
30	05-03-2017	03-31-2017	10-Q
31	02-17-2017	12-31-2016	10-K
32	11-03-2016	09-30-2016	10-Q
33	08-03-2016	06-30-2016	10-Q
34	05-04-2016	03-31-2016	10-Q
35	02-19-2016	12-31-2015	10-K
36	11-05-2015	09-30-2015	10-Q
37	08-04-2015	06-30-2015	10-Q
38	05-06-2015	03-31-2015	10-Q
39	02-27-2015	12-31-2014	10-K
40	11-06-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

abbott-laboratories-recalls-some-sensors-for-its-popular-freestyle-libre-3-glucose-monitoring-system

Abbott Laboratories Recalls Some Sensors F...
09/05/2024 18:45:24

Abbott recalls some FreeStyle Libre 3 sensors due to incorrect glucose readings, risking severe health issues.

Abbott's Lingo Continuous Glucose Monitor ...
09/05/2024 13:10:20

Designed for people interested in improving their overall health and wellnessProvides real-time glucose data and personal coach...

Abbott Initiates Clinical Study Evaluating...
09/04/2024 13:04:40

The U.S. FDA granted Abbott Breakthrough Device designation to explore deep brain stimulation (DBS) for treatment-resistant dep...

looking-into-abbott-laboratoriess-recent-short-interest

Looking Into Abbott Laboratories's Recent ...
08/29/2024 15:30:19

diagnostic-giants-labcorp-roche-to-ramp-up-testing-capacity-amid-global-concerns-over-new-mpox-strain

Diagnostic Giants Labcorp, Roche To Ramp U...
08/26/2024 17:36:31

Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Qu...

dexcoms-stelo-device-brings-affordable-continuous-glucose-monitoring-to-type-2-diabetes-patients

Dexcom's Stelo Device Brings Affordable Co...
08/26/2024 15:39:06

DexCom's Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor, is now available without a ...

U.S. CDC Says Free At Home, Covid 19 Test ...
08/23/2024 15:35:46

- Press Conference

Abbott Laboratories Stock: A Deep Dive Int...
08/22/2024 18:00:57

Citigroup Maintains Buy on Abbott Laborato...
08/22/2024 15:35:33

Citigroup analyst Joanna Wiensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the price target from $119 t...

abbott-laboratories-nu-holdings-and-more-on-cnbcs-final-trades

Abbott Laboratories, Nu Holdings And More ...
08/22/2024 12:48:21

Abbott Laboratories has a strong pipeline and the stock is starting to move, according to Karen Firestone of Aureus Asset Manag...

CNBC Halftime Report Final Trades: Abbott ...
08/21/2024 17:01:16

'Abbott Advances Heart Failure Management ...
08/21/2024 13:14:00

https://abbott.mediaroom.com/2024-08-21-Abbott-Advances-Heart-Failure-Management-with-Aspirin-Free-Regimen-for-Patients-Receivi...

Abbott's AVEIR DR, World's First Dual Cham...
08/15/2024 17:46:02

- Reuters

WHO Says Expert Committee Will Propose Ado...
08/14/2024 17:55:52

- Reuters

Government Of Quebec Has Expanded Public R...
08/08/2024 13:04:26

Abbott (NYSE:ABT) today announced that the Government of Quebec's Régie de l'assurance maladie du Québec (RAMQ) publish...

Live On CNBC, Karen Firestone Announces Bo...
08/07/2024 16:30:25

Abbott Announces Global Partnership With M...
08/07/2024 12:13:17

Cadrenal Therapeutics And Abbott Collabora...
08/06/2024 13:27:11

Cadrenal Therapeutics, Inc., (NASDAQ:CVKD), a biopharmaceutical company developing tecarfarin, a late-stage, new-generation Vi...

jim-cramer-says-this-home-improvement-chain-is-a-buy-ahead-of-fed-rate-cut-cycle-i-would-pick-some-up-tomorrow

Jim Cramer Says This Home Improvement Chai...
07/31/2024 13:08:49

Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit fro...

Barclays Maintains Overweight on Abbott La...
07/29/2024 15:35:39

Barclays analyst Matt Miksic maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $14...

Dysfunction, Heartbreak And Love: 11 Most ...
02/14/2017 22:40:07

Canada's Plan To Fight Opioid Addiction Mi...
08/08/2016 20:59:34